The authors observed a high rate of suicide (6/140 patients, 4.3%) in a large cohort of patients with movement disorders treated with deep brain stimulation (DBS). Apparent risk factors included a previous history of severe depression and multiple successive DBS surgeries, whereas there was no relationship with the underlying condition, DBS target, electrical parameters, or modifications of treatment. Paradoxically, all patients experienced an excellent motor outcome following the procedure. The authors propose that patients at high risk for suicide should be excluded from DBS surgery.
Patients and methods. From late 1994 to early 2004, we followed 140 patients with DBS-treated movement disorders, most of them screened, implanted, and followed at our center. Neurologic conditions requiring DBS were PD, ET, primary and secondary dystonias, and multiple sclerosis-associated tremor. DBS was bilateral in all patients, and depending on the treated condition, brain targets were motor nuclei of the thalamus, the globus pallidus pars interna (GPi), or the subthalamic nucleus (STN). For PD, clinical assessment included, besides repeated visits for motor evaluation and DBS parameter adjustments, the formal administration of preoperative and postoperative Unified Parkinson's Disease Rating Scale and other appropriate scales on a 6-month basis, an extensive battery of neuropsychological tests once a year, and various scales for depression and anxiety. When required, depressive patients were treated and followed by a psychiatrist on a regular basis.
Results. During the 9-year follow-up period, 6 of the 140 DBS-treated patients committed suicide, corresponding to an overall prevalence of 4.3%. Demographics and relevant clinical variables of these patients are detailed in the table. Characteristics shared by most of these suicide patients were as follows: 1) There was a majority of young males with PD (four cases), ET (one case), and postanoxic dystonia (one case) 3 lasting for 22.3 years (range 6 to 52 years); 2) four of six patients had two successive DBS surgeries, the current target and electrical parameters of stimulation being different in each patient (Patient 5 had bilateral GPi and STN stimulation simultaneously and Patient 6 was stimulated on one side only at the time of death); 3) all but one had a previous history of severe depression and other psychiatric features, some with suicide attempt or ideations prior to DBS; 4) death by suicide occurred 3.1 years (range 4 months to 7 years) after the last DBS surgery (suicide was unannounced but long prepared in most, sometimes with the help of an euthanasia group; method of suicide was violent in three); 5) four patients were treated with antidepressants or followed by a psychiatrist or both at the time of death; 6) DBS restored a good to excellent motor function to all patients, three of whom were receiving no medication for movement disorders at the time of death (no recent changes in electrical parameters or drug were performed); 7) none was demented.
Discussion. In our cohort of 140 patients with various DBS-treated movement disorders, there were 6 cases of suicide over a 9-year period. This 4.3% prevalence is much higher than that of the general population and dramatically contrasts with a usually reduced suicide rate in PD where it has been estimated to be 10 times lower than in the general population. 8 This observation is consistent with DBS being a possible risk factor for suicide completion in the population of movement disorders patients. Such increased risk is further supported by recent observations of acute depression, worsening of a previous depression, or suicidal thoughts in PD patients treated with STN DBS 2,5-7 or GPi DBS 9 and is in agreement with reports of 12.5% of patients presenting suicidal ideations during the first year after surgery 2 and of about 6% of postoperative suicide attempts in patients followed over several years.
The patients reported here shared common features that may allow us to delineate some risk fac- tors for suicide after DBS. First, they exhibited several general characteristics for increased suicidal risk: all but one were young men with a chronic neurologic condition, and most had episodes of severe depression before or during the course of the disease prior to DBS, yet only two had frank suicidal ideations or suicide attempts. Some also exhibited bipolar mood swings, anxiety, irritability, paranoia, and behavioral disturbances. However, because depression was not uncommon in the whole cohort, 2 the presence of depression alone could not predict the suicide decision in these particular individuals. Second, four patients underwent two sequential DBS implantations in different target sites, whereas such multiple surgeries represent only 13% of the whole cohort. Third, all experienced a remarkable improvement of motor function following DBS surgery as compared with their previous neurologic status. On the other hand, the increased risk of suicide appeared independent of diagnosis (PD, dystonia, ET) or target location (STN, GPi, nucleus ventralis oralis anterior, nucleus ventralis intermediate medial). Furthermore, electrical parameters were kept stable for weeks and are unlikely to have contributed to suicidal thoughts, like those demonstrated in a recent prospective study, 9 where significant mood changes were produced acutely in DBS patients by modifying stimulation parameters in either the STN or the GPi. Similarly, antiparkinsonian medications were unchanged or discontinued over weeks to months, reasonably ruling out the possibility of an acute dopaminergic withdrawal syndrome precipitating the suicide attempt. Finally, no patient was demented, and cognitive status showed no postoperative changes. Therefore, based on the above features, we hypothesize that DBS may globally increase the risk of suicide by chronic rather than acute mechanisms that may unravel or facilitate a decision to act out in at-risk patients. These mechanisms are putative, and more than one factor may be involved simultaneously in an individual patient. One hypothesis relies on the unwanted spread of current to nonmotor, associative or limbic, parts of the STN or GPi or to adjacent structures such as the ventral tegmental area. Although this possibility may play a role in acute mood changes occasionally observed in some cases, it appears less likely in our patients because suicide completion occurred years after DBS surgery, could not be related to recent parameter modifications, and was also observed with stimulation of thalamic motor nuclei. Another explanation is based on the observation that all six patients benefited from considerable functional improvement as a result of DBS, so that suicide appeared untimely and grossly paradoxical in view of the long-awaited, highly satisfactory motor function restored at the time of death. This observation shares similarities with reports of a high prevalence of postoperative depression and suicides after successful treatment for refractory epilepsy, 10 where unrealistic hopes about surgery are projected. Similarly, it is possible that an irresistible quest for more improvement may be the driving force behind multiple interventions in such patients. Finally, other mechanisms underlying these suicides may rely on deleterious psychopathologic dynamics like the "burden of health" concept, whereby a restored normal life may somehow become unacceptable, or a postsurgery role reversal, by which patients may lose their identity as ill in their personal environments.
Our observation of an increased risk of suicide in patients treated by DBS underscores the importance of a thorough preoperative psychiatric evaluation and the necessity of sustained postoperative psychiatric support, as already suggested by retrospective [3] [4] [5] and prospective 2 studies, particularly in patients presenting other risk factors for suicide. It also suggests that chronic DBS-related risk of suicide may be higher in good responders and in patients seeking multiple surgeries. This study should draw the attention of the medical community toward the potential issue of DBS being an independent facilitating factor for suicide attempts in at-risk patients and an underestimated but possibly major complication of this surgery. We propose that patients exhibiting the aforementioned risk factors should be regarded with extreme caution when considering DBS and should be excluded if the preoperative risk of suicide appears significant.
